IAMIambic Therapeutics
Clinical-stage biotech integrating proprietary large-scale AI with automated chemistry/biology experimentation for drug discovery.
Company description (source: StockAnalysis)
Iambic Therapeutics is a technology and clinical-stage life sciences company pursuing a fundamental shift in the biopharmaceutical industry. Our mission is to make better technology for better medicines. We do this by integrating leading proprietary, large-scale artificial intelligence (AI) with automated, scalable chemistry and biology experimentation. We call this approach molecular superintelligence. Instead of treating each stage of drug discovery as a distinct technological challenge, we have developed a unified, intelligent platform desig...
51CFO matches you with Western CFOs who have each run a full US IPO — plus other C-level talent. First shortlist within 48 hours; free 30-minute listing-readiness read.
Talk to us